873957-41-6

Basic information

• Product Name: 1-[3',4'-O-isopropylidene-6'-O-(4-toluoyl)-β-D-psicofuranosyl]uracil
• Synonyms: 1-[3',4'-O-isopropylidene-6'-O-(4-toluoyl)-β-D-psicofuranosyl]uracil
• CAS NO: 873957-41-6
• Molecular Weight: 432.43
• Mol File: 873957-41-6.mol

Chemical Properties

• CAS DataBase Reference: 1-[3',4'-O-isopropylidene-6'-O-(4-toluoyl)-β-D-psicofuranosyl]uracil(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[3',4'-O-isopropylidene-6'-O-(4-toluoyl)-β-D-psicofuranosyl]uracil(873957-41-6)
• EPA Substance Registry System: 1-[3',4'-O-isopropylidene-6'-O-(4-toluoyl)-β-D-psicofuranosyl]uracil(873957-41-6)

Safety Data

• Hazardous Substances Data: 873957-41-6(Hazardous Substances Data)

Upstream product

• 873957-37-0 1-[1'-O-acetyl-3',4'-O-isopropylidene-6'-O-(4-toluoyl)-β-D-psicofuranosyl]uracil 
• 873957-49-4 1-[3',4'-O-isopropylidene-6'-O-methanesulfonyl-β-D-psicofuranosyl]uracil 
• 17264-54-9 sodium p-methylbenzoate 
• 107367-34-0 1-[3',4'-O-isopropylidene-β-D-psicofuranosyl]uracil 
• 873957-47-2 1-[2,1'-anhydro-3',4'-O-isopropylidene-6'-di-O-methanesulfonyl-β-D-psicofuranosyl]uracil 
• 873957-36-9 1,2-di-O-acetyl-3,4-O-isopropylidene-6-O-(4-toluoyl)-α-D-psicofuranose 
• 873957-44-9 1-[3',4'-O-isopropylidene-1',6'-di-O-methanesulfonyl-β-D-psicofuranosyl]uracil 
• 344905-99-3 6-O-(4-toluoyl)-1,2:3,4-di-O-isopropylidene-β-D-psicofuranose 
• 1039097-50-1 6-O-(4-toluoyl)-1,2:3,4-di-O-isopropylidene-D-psicofuranose 
• 66-22-8 uracil 
• 34626-95-4 1,2:3,4-di-O-isopropylidene-β-D-psicofuranose 
• 874-60-2 4-methyl-benzoyl chloride 

Downstream Products

• 873957-43-8 1-[1',3'-O-anhydro-6'-O-(4-toluoyl)-β-D-psicofuranosyl]uracil 
• 1039097-58-9 1-[3',4'-O-isopropylidene-6'-O-(4-toluoyl)-β-D-psicofuranosyl]-6-iodouracil 
• 1039097-61-4 1-[1'-O-(t-butyldimethylsilyl)-3',4'-O-isopropylidene-6'-O-(4-toluoyl)-β-D-psicofuranosyl]-6-iodouracil 
• 420109-53-1 1-[3',4'-O-isopropylidene-1'-O-methanesulfonyl-6'-O-(4-toluoyl)-β-D-psicofuranosyl]uracil 

Relevant articles and documents

Synthesis and anti-HCV activity of 1-(1′,3′-O-anhydro-3′-C-methyl-β-d-psicofuranosyl)uracil

Synthesis of a novel 1′,2′-oxetane-uridine bearing a 2′-C-methyl substituent, [1-(1′,3′-O-anhydro-3′-C-methyl-β-d-psicofuranosyl)uracil], is described. Key to its construction was the use of 6-O-(p-toluoyl)-1,2:3,4-di-O-isopropylidene-3-C-methyl-d-psicofu

PYRIMIDINE DERIVATIVES AS ANTICANCER AGENTS

The present invention includes methods of treating or preventing cancer by administering an effective amount of 6-substituted pyrimidine derivatives of the Formula I to a subject need thereof:

ODCASE INHIBITORS FOR THE TREATMENT OF MALARIA

The present invention includes methods of treating or preventing malaria by administering an anti-malarial effective amount of 6-substituted uridine derivatives to a subject need thereof. The invention also includes new 6-substituted uridine derivatives for use as therapeutics, in particular to treat malaria.

Facile preparation of the oxetane-nucleosides

Efficient and practical large scale synthesis of suitably protected 1′, 2′-oxetane locked purine and pyrimidine nucleosides for incorporation in oligo-DNA or -RNA by solid-phase synthesis is reported. A high regio and stereoselectivity with preferential f